<DOC>
	<DOCNO>NCT01499056</DOCNO>
	<brief_summary>Osteoarthritis hip common type osteoarthritis cause significant problem . First-line management patient osteoarthritis consist weight reduction , education , analgesic medication . If necessary , invasive treatment like total hip replacement perform patient . The objective study ass safety bone marrow mesenchymal stem cell ( BM-MSCs ) implantation patient hip osteoarthritis</brief_summary>
	<brief_title>Mesenchymal Stem Cell Transplantation Osteoarthritis Hip Joint</brief_title>
	<detailed_description>This phase one clinical study design investigate safety intra-articular injection culture autologous BM-MSCs patient severe hip osteoarthritis candidate total hip replacement . All subject undergo bone marrow aspiration . Autologous MSCs extract culture 4 week . Patients receive intra-articular injection culture MSCs guide fluoroscopy . Paraclinical study ( X-Ray MRI ) do 6 month treatment . Pain relief functional improvement joint assess VAS , WOMAC , Harris Hip Score questionnaire treatment , 2 6 month treatment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<criteria>Osteoarthritis diagnose MRI End stage osteoarthritis candidate total hip replacement Pregnancy lactate Positive test HIV , HCV , HBV Active neurologic disorder End organ damage Uncontrolled endocrine disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>hip joint</keyword>
	<keyword>mesenchymal stem cell</keyword>
</DOC>